- Country: Ukraine
- Summary: Code Dc 021:2015 - 33600000-6 Pharmaceutical Products. Lenograstim, Lyophilisate for Solution for Injection, 33.6 Million Iu (263 Μg) Per 1 Ml, Amp., Fl., Spr.
- UAT Ref No: 87510661
- Deadline: 26 Aug 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 86887.80
- Notice Type: Tender
- Document Ref. No.: UA-2023-08-18-010027-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Code DC 021:2015 - 33600000-6 Pharmaceutical products. Lenograstim, lyophilisate for solution for injection, 33.6 million IU (263 μg) per 1 ml, amp., fl., spr.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCode Dc 021:2015 - 33600000-6 Pharmaceutical Products. Lenograstim, Lyophilisate for Solution for Injection, 33.6 Million Iu (263 Μg) Per 1 Ml, Amp., Fl., Spr. - Ukraine Tender
The DEPARTMENT OF HEALTH PROTECTION OF THE KYIV REGIONAL STATE ADMINISTRATION, a Government sector organization in Ukraine, has announced a new tender for Code Dc 021:2015 - 33600000-6 Pharmaceutical Products. Lenograstim, Lyophilisate for Solution for Injection, 33.6 Million Iu (263 Μg) Per 1 Ml, Amp., Fl., Spr.. This tender is published on UkraineTenders under UAT Ref No: 87510661 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-08-26.
The estimated tender value is UAH 86887.80, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
